Association between glucolipid metabolic indicators and the risk of suspected precocious puberty in children living with obesity: a retrospective cohort study - Report - MDSpire

Association between glucolipid metabolic indicators and the risk of suspected precocious puberty in children living with obesity: a retrospective cohort study

  • By

  • Tingting Hao

  • Yifan Li

  • Qingmei Zhang

  • June 18, 2026

  • 0 min

Share

Linking glucolipid metabolic markers to precocious puberty in obese children

Overview

This study investigates the association between glucolipid metabolic indicators and suspected precocious puberty (PP) in obese children. Findings indicate that higher insulin resistance, triglycerides, and uric acid levels are linked to suspected PP, while higher HDL-C levels appear protective.

Background

Precocious puberty can lead to various health issues, including reduced adult height and psychological challenges. The rising incidence of precocious puberty, particularly in children with obesity, underscores the need for identifying metabolic risk factors. Understanding these associations can inform early intervention strategies to mitigate long-term health risks.

Data Highlights

Metabolic IndicatorSuspected PP GroupNon-PP Group
FPGHigherLower
FINSHigherLower
HOMA-IRHigherLower
TGHigherLower
HDL-CLowerHigher
Bone Age Advancement1.88 ± 0.64 years0.86 ± 0.48 years

Key Findings

  • Suspected PP group had significantly higher FPG, FINS, HOMA-IR, TG, TC, LDL-C, and uric acid levels.
  • Lower HDL-C levels were observed in the suspected PP group compared to non-PP.
  • Logistic regression identified HOMA-IR, TG, and uric acid as independent risk factors for suspected PP.
  • Higher HDL-C levels were found to be protective against suspected PP.
  • Bone age advancement was significantly greater in the suspected PP group.

Clinical Implications

Healthcare providers should consider metabolic monitoring in obese children, particularly those showing signs of precocious puberty. Early identification of insulin resistance and dyslipidemia may facilitate timely interventions to prevent adverse outcomes associated with early puberty.

Conclusion

The study highlights a significant association between glucolipid metabolic markers and suspected precocious puberty in obese children, emphasizing the need for early metabolic assessment in this population.

Related Resources & Content

  1. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Links Between Growth Rates of Body Mass Index, Body Composition, and Cardiometabolic Risk Factors in Preschoolers in China
  2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Elevated Free IGF-1 Levels and Accelerated Growth Observed in Obese Prepubertal Children Despite Lowered Pappalysin Concentrations
  3. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Circulating DLK1 Levels in Healthy Girls and Those With Precocious Puberty During Minipuberty and Pubertal Development
  4. Central precocious puberty: an Endocrine Society clinical practice guideline, 2023
  5. The Journal of Clinical Endocrinology & Metabolism — Correspondence from Li and Luo: The Link Between Obesity and Hyperandrogenemia in a Nationally Representative Cohort of US Girls Aged 6 to 18 Years
  6. 2023 AAP Clinical Guidelines for Treatment of Obesity
  7. Central precocious puberty: an Endocrine Society clinical practice guideline | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic
  8. Risk factors for precocious puberty: A systematic review and meta‑analysis - ScienceDirect

Original Source(s)

Related Content